StudyFinder
Search Results
1 Study Matches
A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy
This study is for patients with active Systemic Lupus Erythematosus(SLE) to test the effect and safety of different doses of the experimental drug AMG 570. To see if AMG 570 is a treatment option for SLE patients who are not responding to current standard of care.
Jamie Carter - at jcarter3@pennstatehehalth.psu.edu or 717-531-0003, ext=283833
All
18 year(s) or older
NCT04058028
STUDY00014615
Inclusion Criteria:
Diagnosis of SLEExclusion Criteria:
Active infectionPregnant or breastfeeding
Arthritis & Rheumatic Diseases